Teva Pharmaceutical Prices $4.9 Billion Senior Notes Offering

MT newswire2026/09/10 10:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

06:36 AM EDT, 09/10/2026 (MT Newswires) -- Teva Pharmaceutical Industries (TEVA) has priced an offering of about $4.9 billion of senior notes across euro- and dollar-denominated tranches, the company said Thursday. The offering includes 1 billion euros ($1.16 billion) of 4.25% senior notes due 2033; 500 million euros of 4.625% notes due 2036; $1 billion of 5.5% notes due 2034; $1 billion of 5.75% notes due 2037, and $1.2 billion of 5.25% notes due 2032, the company said. Net proceeds, together with cash on hand, will be used to fund conditional redemptions, pay fees and expenses, as well as for general corporate purposes. Settlement is expected on or about Sept. 16, subject to customary closing conditions, Teva said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.

华尔街见闻•2026/09/12 04:41